MR

Mangesh Rangnath Sanap

Active Director Designated Partner DIN 07903987
DIN 07903987 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Mangesh Rangnath Sanap

Data last updated:

Mangesh Rangnath Sanap is a Designated Partner at Pharma Choice Llp (since 2017). The company operates in Pharma.

DIN 07903987
Primary Designation Designated Partner
Industry Pharma
First Appointment 15 Sep 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Sep 20172017Active

Board colleagues of Mangesh Rangnath Sanap

NameDINCompanyDesignation
Akshay Rao Harishchandra07902566Pharma Choice LlpDesignated Partner
Ganesh Rangnath Sanap07901052Pharma Choice LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Pharma Choice Llp
Premium access

Shareholding and investment profile for Mangesh Rangnath Sanap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mangesh Rangnath Sanap

Mangesh Rangnath Sanap currently holds 1 directorship: Pharma Choice Llp (Designated Partner, since 15 Sep 2017).

Mangesh Rangnath Sanap was first appointed on 15 Sep 2017 as Designated Partner at Pharma Choice Llp.

The current boards of Mangesh Rangnath Sanap's companies include Akshay Rao Harishchandra (Pharma Choice Llp), Ganesh Rangnath Sanap (Pharma Choice Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available